Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study

BACKGROUND: Channeling bias may occur when a newly marketed drug and an established drug, despite similar indications, are prescribed to patients with different prognostic characteristics (ie, confounding). AIM: To investigate channeling bias and its impact on relative effectiveness of glucagon-like...

Descripción completa

Detalles Bibliográficos
Autores principales: Ankarfeldt, Mikkel Z, Thorsted, Brian L, Groenwold, Rolf HH, Adalsteinsson, Erpur, Ali, M Sanni, Klungel, Olaf H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5261549/
https://www.ncbi.nlm.nih.gov/pubmed/28176886
http://dx.doi.org/10.2147/CLEP.S124054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5261549/
https://www.ncbi.nlm.nih.gov/pubmed/28176886
http://dx.doi.org/10.2147/CLEP.S124054

Ejemplares similares